Canadian Cannabis: Strategic Options
As the various Canadian Cannabis companies jockey for position in the recreational marijuana market it’s time to consider which are best placed to meet the market strategically.
As the various Canadian Cannabis companies jockey for position in the recreational marijuana market it’s time to consider which are best placed to meet the market strategically.
Thomas Fairfull, President and Chief Executive Officer of FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE) (OTC:FSDDF), is pleased to announce the appointment of a Special Committee of the Board of Directors to focus on Merger and Acquisition Opportunities and also the appointment of Donal Carroll as interim Chief Financial Officer.
Triumph Gold Corp. (TSX-V:TIG) (“Triumph” or the “Company”) is pleased to announce that pursuant to its stock option plan, the Company is issuing 800,000 options to officers and directors. The options are priced at $0.40 and are valid for a period of 5 years. The stock options will vest 25% immediately, 25% after six months, 25% after twelve months and 25% after eighteen months.
FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTC: FSDDF), is pleased to report that it has traded over one Billion Class B subordinate voting shares and has broken the one year consecutive days of trading record on the Canadian Securities Exchange (“CSE”) in less than two months of trading. During the period of May 29, 2018 to July 18, 2018, the Company traded exactly 1,028,297,481 Class B subordinate voting shares on the Canadian Securities Exchange (“CSE”). Comparatively, the largest amount traded prior on the CSE in a one year period of consecutive days was 989,295,522. This is the largest total quantity of share volume ever traded by a CSE listed issuer within one year of consecutive days of trading as confirmed by the CSE.
This is a great idea: an investor bootcamp in the middle of Ontario’s cottage country in the middle of the summer.
Over at Stockhouse there is an excellent Q&A with White Gold’s CEO David D’Onofrio.
Manganese X Energy Corp. (TSXV: MN) (FSE: 9SC2) (TRADEGATE: 9SC2) (OTC Pink: SNCGF) ( “MN” or the “Company”). The Company is pleased to report that it recently received from the National Research Council (“NRC/CNRC”) a research proposal: “The potential of ore upgrading and purification techniques to produce battery grade material (high purity 99.999%).”
MGX Minerals Inc. (“MGX” or the “Company”) (CSE:XMG) (FKT:1MG) (OTCQB:MGXMF) is pleased to report it has completed the previously announced diamond drill program on its Koot silicon project (“Koot” or the “Project”) in British Columbia. A total of 782 meters (2,565 feet) of drilling were completed across 10 drill holes. Drill core has been split and sent to ALS Minerals in North Vancouver, British Columbia for special carbide pulverizing disc preparation and ME-ICP06 whole rock analysis. The Summer 2018 drill program was designed to define an initial N.I. 43-101 resource estimate. Additional drill work is planned at two of the Company’s nearby silicon properties with the goal of also defining a resource. Historic Exploration conducted by COMINCO during the 1980’s outlined a mineralized zone spanning approximately 400 meters consisting of high-purity silicon dioxide (SiO2).
Marathon Gold Corporation (“Marathon” or the “Company”) (TSX:MOZ) is pleased to announce that it has completed its previously announced bought deal prospectus offering of 2,900,000 flow-through common shares in the capital of the Company (“FT Shares”) at a price of $1.05 per FT Share and 5,900,000 common shares in the capital of the Company (“Common Shares”) at a price of $0.85 per Common Share for gross proceeds to the Company of $8,060,000 (the “Offering”). The Offering was conducted by a syndicate of underwriters co-led by Haywood Securities Inc. and RBC Capital Markets and including Canaccord Genuity Corp., Laurentian Bank Securities Inc. and Raymond James Ltd.
FSD Pharma Inc. (“FSD Pharma”) (CSE:HUGE) (OTC:FSDDF) today announced that its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”) has entered into a non-binding memorandum of understanding (“MOU”) with High Tide Ventures Inc. (“High Tide”) dated July 18, 2018 to supply the Saskatchewan market on a wholesale basis with up to 5,000 kilograms of cannabis products over the next year when available. FSD Pharma is working together with Auxly (formerly Cannabis Wheaton Income Corp.) (TSX.V:XLY) to achieve its mission to develop the largest hydroponic indoor cannabis cultivation facility in Cobourg, Ontario, Canada.